Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 2/20 | 0.45 |
| ▸ | TERT | O14746 | 4/20 | 0.42 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.40 |
| ▸ | CYCS | P99999 | 3/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.37 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.36 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.36 |
| ▸ | CACNG8 | Q8WXS5 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20405347 | 0.90 | TOP1 (0.38) | TOP1TERTABCG2CYCSENPP2 | |
| SCHEMBL29408466 | 0.86 | TERT (0.45) | TOP1TERTABCG2CYCSENPP2 | |
| SCHEMBL9581910 | 0.86 | TERT (0.45) | TOP1TERTABCG2CYCSENPP2 | |
| SCHEMBL5011964 | 0.84 | TERT (0.49) | TOP1TERTABCG2CYCSENPP2 | |
| SCHEMBL5016668 | 0.84 | TERT (0.49) | TOP1TERTABCG2CYCSENPP2 | |
| SCHEMBL479431 | 0.84 | TERT (0.49) | TOP1TERTABCG2CYCSENPP2 | |
| SCHEMBL17251679 | 0.82 | ABCG2 (0.41) | TOP1TERTABCG2CYCSENPP2 | |
| SCHEMBL18593559 | 0.80 | ABCG2 (0.41) | TOP1TERTABCG2ENPP2 | |
| SCHEMBL17251726 | 0.80 | TOP1 (0.58) | TOP1TERTABCG2CYCSENPP2 | |
| SCHEMBL2868186 | 0.79 | TERT (0.39) | TOP1TERTABCG2CYCSENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3140312-B1 | PORPHYRIN MOLECULAR CATALYSTS FOR SELECTIVE ELECTROCHEMICAL REDUCTION OF CO2 INTO CO | CENTRE NAT RECH SCIENT (FR) | 2018-07-25 | — | — | EP | disclosed |
| US-20170067168-A1 | PORPHYRIN MOLECULAR CATALYSTS FOR SELECTIVE ELECTROCHEMICAL REDUCTION OF CO2 INTO CO | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2017-03-09 | — | — | US | disclosed |
| US-20170067168-A1 | PORPHYRIN MOLECULAR CATALYSTS FOR SELECTIVE ELECTROCHEMICAL REDUCTION OF CO2 INTO CO | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2017-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170067168-A1 | PORPHYRIN MOLECULAR CATALYSTS FOR SELECTIVE ELECTROCHEMICAL REDUCTION OF CO2 INTO CO | CYC1, MT-CO2, MT-CO1 | TOP1 1138/4885TERT 738/4885ABCG2 4362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.